Valuation: Clover Corporation Limited

Market Cap 151M 108M 92.79M 86.82M 79.48M 149M 10.36B 1.03B 400M 5.21B 407M 398M 17.22B P/E 2026 *
15.5x
P/E 2027 * 11.3x
Enterprise Value 149M 107M 91.38M 85.5M 78.27M 147M 10.21B 1.01B 394M 5.13B 401M 392M 16.96B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.24x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+1.11%
1 week-4.21%
Current month-5.21%
1 month+5.20%
3 months+5.20%
6 months+22.97%
Current year+15.19%
1 week 0.9
Extreme 0.9
0.96
1 month 0.88
Extreme 0.88
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.11%-4.21%+62.50%-12.50% 107M
-5.39%-6.20%+9.21%+69.26% 12.7B
-7.67%+10.96%-11.03%+386.45% 10.15B
-1.34%-5.33%-22.72%-49.15% 2.42B
-1.86%+1.37%-15.22%-3.43% 1.51B
-0.09%+0.11%+24.62%+75.58% 1.38B
+0.63%+6.17%+34.57%-17.23% 1.33B
+4.37%+4.62%-72.45%-73.31% 1.18B
+4.13%-1.18%-40.18% - 1.05B
+1.42%+1.66%-62.36%-67.35% 962M
Average -0.50%-1.98%-9.31%+34.26% 3.28B
Weighted average by Cap. -4.30%-3.52%-5.33%+145.13%

Financials

2026 *2027 *
Net sales 94M 67.38M 57.72M 54M 49.43M 92.77M 6.45B 638M 249M 3.24B 253M 247M 10.71B 116M 83.22M 71.29M 66.7M 61.06M 115M 7.96B 788M 307M 4B 312M 306M 13.23B
Net income 9.8M 7.02M 6.02M 5.63M 5.15M 9.67M 672M 66.52M 25.94M 338M 26.38M 25.8M 1.12B 13.5M 9.68M 8.29M 7.76M 7.1M 13.32M 926M 91.63M 35.73M 465M 36.34M 35.54M 1.54B
Net Debt -2.3M -1.65M -1.41M -1.32M -1.21M -2.27M -158M -15.61M -6.09M -79.24M -6.19M -6.06M -262M -7.2M -5.16M -4.42M -4.14M -3.79M -7.11M -494M -48.87M -19.06M -248M -19.38M -18.96M -820M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
24/08/26 A$0.9100 +1.11% 5,064
21/08/26 A$0.9000 -2.70% 20,868
20/08/26 A$0.9250 +1.65% 5,020
19/08/26 A$0.9100 -0.55% 5,710
18/08/26 A$0.9150 -2.14% 741
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9100AUD
Average target price
1.280AUD
Spread / Average Target
+40.66%

Annual profits - Rate of surprise